Zobrazeno 1 - 10
of 19
pro vyhledávání: '"I V Menshikova"'
Publikováno v:
Научно-практическая ревматология, Vol 47, Iss 4, Pp 84-89 (2009)
Objective. To determine indications to and efficacy of arthroscopic synovectomy (AS) via anteriolateral portal in rheumatoid arthritis (RA) with knee joint synovitis. Material and methods. 139 pts with RA and knee joint synovitis were included. Knees
Externí odkaz:
https://doaj.org/article/646bb02aeeea4b6dab8b4821f4378004
Publikováno v:
Современная ревматология, Vol 0, Iss 2, Pp 33-37 (2009)
Objective: to compare the data of knee joint X-ray and arthroscopic studies in the presence of rheumatoid synovitis. Subjects and methods. Sixty-seven patients who had undergone 72 arthroscopic synovectomic operations on 72 joints for chronic knee-jo
Externí odkaz:
https://doaj.org/article/6284ab79a4444c5ea9ddd4faf043ec66
Autor:
R M Balabanova, V I Makolkin, N A Shostak, N V Chichasova, Yu A Olyunin, D V Goryachev, Т К Loginova, A A Ryabkova, N V Petukhova, I V Menshikova, E V Igolkina, K A Chizhova, E L Nasonov
Publikováno v:
Терапевтический архив, Vol 79, Iss 5, Pp 28-32 (2004)
Aim. To assess leflunomide efficacy and tolerance in patients with rheumatoid arthritis (RA) during the first four months of the treatment. Material and methods. The study included 200 RA patients treated in four Moscow clinical centers. Leflunomide
Externí odkaz:
https://doaj.org/article/edbb6b9006c8435d83ba051d8b0b8112
Autor:
A. Yu. Feklistov, L. D. Vorobieva, O. G. Alekseeva, A. V. Sukhinina, I. A. Andrianova, I. V. Menshikova, V. N. Sorotskaya, E. G. Zotkin
Publikováno v:
Modern Rheumatology Journal. 16:64-72
Objective: to evaluate the effectiveness of therapy with AMBENE®Bio (AB) in comparison with the comparator drug (bioactive concentrate of small marine fish, BCSMF) in patients with osteoarthritis (OA) of large and small joints in routine clinical pr
Autor:
Yu. N. Belenkov, I. V. Menshikova, I. S. Ilgisonis, Yu. I. Naimann, Yu. V. Pak, I. R. Kolosova, A. S. Rakovskaya
Publikováno v:
Сеченовский вестник, Vol 11, Iss 2, Pp 29-39 (2020)
Hydroxychloroquine (HCH) is included in guidelines for treatment of novel coronavirus infection (COVID-19). Data on increased risk of cardiovascular complications when using it have been published. Aim. To evaluate the safety and tolerability of HCH
Immune-mediated adverse rheumatic reactions following administration of immune checkpoint inhibitors
Autor:
I. V. Menshikova, V. V. Strogonova
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 4, Pp 443-446 (2020)
Immunotherapy with immune checkpoint inhibitors (ICIs) opens up new prospects in treatment of malignancies, although this novel therapy quite often results in development of immune-related adverse events (irAEs), which can limit their clinical use. I
Autor:
I. V. Menshikova, V. V. Strogonova
Publikováno v:
Современная ревматология, Vol 13, Iss 2, Pp 80-83 (2019)
Objective: to analyze the efficacy of tofacitinib (TOFA) in patients with an advanced stage of rheumatoid arthritis (RA) and previous methotrexate (MTX) failure according to comprehensive clinical and laboratory examination.Patients and methods. Nine
Publikováno v:
Современная ревматология, Vol 12, Iss 2, Pp 97-102 (2018)
The main goal of management of patients with osteoarthritis (OA) is analgesic and anti-inflammatory therapy, deceleration of the progression of the disease, and improvement of quality of life. Fast-acting symptomatic drugs (analgesics and nonsteroida
Autor:
A. M. Lila, I. Z. Gaydukova, O. N. Anoshenkova, I. G. Bannikova, I. B. Vinogradova, M. L. Goldman, S. Yu. Davidian, L. P. Evstigneeva, O. E. Epifanova, E. V. Zemerova, A. I. Zagrebneva, L. V. Ivanova, A. K. Karibova, I. V. Menshikova, O. N. Mironenko, M. P. Mikhailova, N. E. Nikulenkova, I. M. Patrikeeva, T. V. Plaksina, G. R. Savvina, R. R. Samigullina, L. E. Sarantseva, J. V. Usacheva, O. P. Ukhanova, G. F. Fatkhullina, A. L. Chudinov, I. A. Shafieva, S. P. Yakupova
Publikováno v:
Современная ревматология, Vol 18, Iss 3, Pp 32-43 (2024)
The efficacy and safety of levilimab (LVL) in patients with active rheumatoid arthritis (RA) has been confirmed in controlled clinical trials. This article presents the results of a preliminary analysis of a non-interventional observational study of
Externí odkaz:
https://doaj.org/article/4031788a32de403ebea6e82d4f01065d
Autor:
Sh. Erdes, V. I. Mazurov, I. Z. Gaydukova, O. N. Anoshenkova, I. B. Vinogradova, Yu. Yu. Grabovetskaya, S. Yu. Davidian, O. E. Epifanova, N. A. Kiryukhina, L. V. Masneva, I. V. Menshikova, O. N. Mironenko, N. E. Nikulenkova, T. V. Povarova, A. N. Polyatika, R. R. Samigullina, A. E. Sizikov, I. N. Totrov, I. F. Umnova, J. V. Usacheva, A. L. Chudinov
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 6, Pp 700-710 (2024)
Background. Netakimab has shown high efficacy in controlled clinical trials in the treatment of patients with ankylosing spondylitis (AS). This article presents results of an observational study of netakimab using in routine clinical practice.Methods
Externí odkaz:
https://doaj.org/article/7e5bc44473f34733b5ff6008d493e861